Skip to main content
DNA Labs India

CEBPA Gene Leukemia, acute myeloid, somatic NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

CEBPA Gene Leukemia, acute myeloid, somatic NGS Genetic Test

Short Name: CEBPA Gene AML NGS Test

Also known as: CEBPA Mutation Test, AML Genetic Test, Leukemia NGS Test

CEBPA Gene Leukemia, acute myeloid, somatic NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in 3 to 4 Weeks. Free home collection in 300+ cities across India.

Next Generation Sequencing (NGS)Adults🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of the CEBPA gene NGS test is to detect somatic mutations in the CEBPA gene associated with acute myeloid leukemia. This information aids in diagnosis, prognosis, and selection of targeted therapies for AML patients.

Test Code
2888
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
3 to 4 Weeks
Fasting Required
No
Method
Next Generation Sequencing (NGS)
Step 1

Sample Collection

No specific preparation required. Inform the doctor about any medications or recent treatments.

Method: Blood draw or FTA card collection

Step 2

Laboratory Analysis

A blood sample will be drawn from a vein in the arm. For FTA card collection, a drop of blood is placed on the card.

Step 3

Report Delivery

Apply pressure to the puncture site to stop bleeding. Resume normal activities.

Timeline: 3 to 4 Weeks

Patient Instructions

1
Before the Test:Consult with a genetic counselor or oncologist to understand the test implications.
2
During the Test:The test involves a simple blood draw or FTA card collection.
3
After the Test:Results will be available in 3-4 weeks. Discuss with your doctor for next steps.

About This Test

Who Should Get This Test

The purpose of the CEBPA gene NGS test is to detect somatic mutations in the CEBPA gene associated with acute myeloid leukemia. This information aids in diagnosis, prognosis, and selection of targeted therapies for AML patients.

How to Prepare

  • Fast for 8-12 hours if required, but not specified for this test
  • Bring identification and doctor's prescription
  • Wear loose clothing for easy blood draw

Doctor's Notes

Reviewed by — MBBS, MD (Pathology) · Reg. No. 21521

"Genetic testing for CEBPA mutations helps in stratifying AML patients for targeted therapies, improving treatment outcomes."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Collection MethodBlood draw or FTA card collection

Sample Stability

Blood samples: stable for 24 hours at room temperature
FTA cards: stable for extended periods at room temperature
Sample Rejection Criteria:
  • Insufficient sample volume
  • Hemolyzed or clotted samples
  • Incorrect sample type

Understanding Your Results

Results indicate the presence or absence of mutations in the CEBPA gene. A positive result suggests a genetic predisposition to AML, while a negative result may not rule out other causes.
📊

Mutation detected

Associated with AML risk; further clinical evaluation and genetic counseling recommended.

📊

No mutation detected

Lower risk for CEBPA-related AML, but other factors may be involved.

⚠️ When to Consult a Doctor:

If you experience symptoms of AML such as persistent fatigue, unexplained bleeding, or frequent infections, consult a hematologist or oncologist immediately.

Limitations

  • May not detect all types of CEBPA mutations
  • Results should be correlated with clinical findings
  • Not a standalone diagnostic tool

Risks & Considerations

  • Minimal risk from blood draw: bruising, infection
  • No significant risks from genetic testing itself

Interfering Factors

  • Hemolyzed blood samples
  • Contaminated DNA samples
  • Recent blood transfusions

Frequently Asked Questions

What is the CEBPA gene NGS test?
It is a genetic test using Next Generation Sequencing to detect mutations in the CEBPA gene associated with acute myeloid leukemia (AML).
Why is this test recommended?
It is recommended for diagnosing AML, guiding treatment decisions, and assessing genetic risk in patients with symptoms or family history.
How is the sample collected?
A blood sample is drawn from a vein, or a drop of blood is placed on an FTA card. Home collection is available.
What is the cost of the test?
The test costs INR 20,000, which includes result analysis and genetic counseling.
How long does it take to get results?
Results are typically available in 3 to 4 weeks.
Is home collection available?
Yes, free home sample collection is available across India for online bookings.
What do the results mean?
A positive result indicates a CEBPA mutation linked to AML risk, while a negative result suggests no such mutation, but clinical correlation is needed.
Are there any risks?
Risks are minimal, such as bruising from blood draw. Genetic testing itself poses no significant risks.
How accurate is the test?
NGS technology provides high accuracy for detecting mutations, but results should be interpreted by a healthcare professional.
Can this test diagnose AML?
It helps in diagnosis by identifying genetic mutations, but AML diagnosis requires clinical evaluation and other tests like bone marrow biopsy.
What should I do if the result is positive?
Consult an oncologist or genetic counselor for further evaluation, treatment options, and family risk assessment.
Is genetic counseling provided?
Yes, a genetic counseling session is included to discuss results and implications.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.